Megasoft (NSE:MEGASOFT) Debt-to-Asset : 0.40 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Megasoft Debt-to-Asset?

Megasoft's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹97.11 Mil. Megasoft's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹1,373.36 Mil. Megasoft's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₹3,659.00 Mil. Megasoft's debt to asset for the quarter that ended in Mar. 2024 was 0.40.

Megasoft Debt-to-Asset Historical Data

The historical data trend for Megasoft's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Megasoft Debt-to-Asset Chart

Megasoft Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.12

0.11

0.10

0.39

0.40

Megasoft Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.39	-	0.39	-	0.40

Competitive Comparison of Megasoft's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Megasoft's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Megasoft's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Megasoft's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Megasoft's Debt-to-Asset falls into.

Megasoft Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Megasoft's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(97.108	+	1373.362)	/	3658.997
	=	0.40

Megasoft's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(97.108	+	1373.362)	/	3658.997
	=	0.40

Megasoft (NSE:MEGASOFT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Megasoft Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Megasoft's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Megasoft (NSE:MEGASOFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (NSE:MEGASOFT) » Definitions » Debt-to-Asset

Traded in Other Exchanges

532408:India

Address

Image Gardens Road, 8th Floor, Unit No. 801B, Plot No. 1, 28 & 29, 98/4/1 to 13, Jain Sadguru Image’s Capital Park, Madhapur, Hyderabad, TG, IND, 500081

Website

http://www.megasoft.com

Megasoft Ltd is focused on Pharma, Aerospace and Defense Electronics areas and is in the process of acquiring a few companies and intends to provide centralized corporate, technology, finance, and leadership/management support services to such subsidiaries/associate companies. The company has invested in Extrovis AG, a company engaged in Pharmaceutical R&D and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a wide range of activities aimed at bringing safe, effective, and high-quality drugs to the market.

Megasoft (NSE:MEGASOFT) Headlines

No Headlines